Catégorie de service: Services d'essais in vitro incluant des tests de libération de médicament et des études de biodispense pour des formes galéniques allant des comprimés aux formulations transdermiques
Échelle de capacité: Cartographie de solutions fournie au cas par cas, soutenant la preuve de concept depuis les premiers stades jusqu'au développement en pharmacologie inverse
Couverture géographique: Fourni depuis l'Inde par Stabicon Life Sciences, au service des besoins mondiaux d'évaluation de l'efficacité et de la sécurité

Autres informations

Description supplémentaire:

Stabicon Life Sciences offers a broad range of in vitro services that serve as alternatives to human testing and are central to efficacy and safety assessment, providing a full suite of drug release assays and biowaiver studies across dosage forms from simple tablets to transdermal formulations. In vitro studies are essential to drug and wellness product development, providing the basis for in vivo clinical studies and helping determine the best delivery model before committing to further development; the company's in vitro analyses can establish proof of concept for a delivery dosage form early on, or support reverse-pharmacology development by clarifying a candidate drug's selectivity and interactions with its intended therapeutic target, with solutions tailored case-by-case to each client's needs.